A detrimental role for nitric oxide synthase-2 in the pathology resulting from acute cerebral injury

Journal of Neuropathology and Experimental Neurology

Volumn 63, Issue 7, 2004, Pages 708-720

  Jones, N C ^a   Constantin, D ^a   Gibson, C L ^a   Prior, M J W ^a   Morris, P G ^a   Marsden, C A ^a   Murphy, Sean ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Aseptic cryogenic cerebral injury; Behavior; Knockout mice; Magnetic resonance imaging; NOS 2; Trauma

Indexed keywords

INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; BRAIN SIZE; COGNITION; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DISEASE SEVERITY; ENZYME ANALYSIS; GENE; GENOTYPE; HISTOPATHOLOGY; LOCOMOTION; MALE; MOUSE; NEUROLOGIC DISEASE; NEUROPATHOLOGY; NONHUMAN; NOS2 GENE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSORIMOTOR FUNCTION; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; WILD TYPE;

EID: 3042794144     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnen/63.7.708     Document Type: Article

References (87)

1. Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987;327:524-26
2. Nakane M, Schmidt HH, Pollock JS, Forstermann U, Murad F. Cloned human brain nitric oxide synthase is highly expressed in skeletal muscle. FEBS Lett 1993;316:175-80
3. Geller DA, Lowenstein CJ, Shapiro RA, et al. Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes. Proc Natl Acad Sci USA 1993;90:3491-95
4. Janssens SP, Shimouchi A, Quertermous T, Bloch DB, Bloch KD. Cloning and expression of a cDNA encoding human endothelium-derived relaxing factor/nitric oxide synthase. J Biol Chem 1992;267:14519-22
5. Christopherson KS, Bredt DS. Nitric oxide in excitable tissues: Physiological roles and disease. J Clin Invest 1997;100:2424-29
6. Griffith OW, Stuehr DJ. Nitric oxide synthases: Properties and catalytic mechanism. Annu Rev Physiol 1995;57:707-36
7. Nussler AK, Billiar TR. Inflammation, immunoregulation, and inducible nitric oxide synthase. J Leukoc Biol 1993;54:171-78
8. Loihl AK, Murphy S. Expression of nitric oxide synthase-2 in glia associated with CNS pathology. Prog Brain Res 1998;118:253-67
9. Kashii S, Mandai M, Kikuchi M, et al. Dual actions of nitric oxide in N-methyl-D-aspartate receptor-mediated neurotoxicity in cultured retinal neurons. Brain Res 1996;711:93-101
10. Dawson VL, Dawson TM, Bartley DA, Uhl GR, Snyder SH. Mechanisms of nitric oxide-mediated neurotoxicity in primary brain cultures. J Neurosci 1993;13:2651-61
11. Lecanu L, Verrecchia C, Margaill I, Boulu RG, Plotkine M. iNOS contribution to the NMDA-induced excitotoxic lesion in the rat striatum. Br J Pharmacol 1998;125:584-90
12. Murphy MP. Nitric oxide and cell death. Biochim Biophys Acta (Bioenergetics) 1999;1411:401-14
13. Virag L, Szabo E, Gergely P, Szabo C. Peroxynitrite-induced cytotoxicity: Mechanism and opportunities for intervention. Toxicol Lett 2003;140-141:113-24
14. Murphy S. Production of nitric oxide by glial cells: Regulation and potential roles in the CNS. Glia 2000;29:1-13
15. Secco DD, Paron JA, de Oliveira SH, Ferreira SH, Silva JS, Cunha Fde Q. Neutrophil migration in inflammation: Nitric oxide inhibits rolling, adhesion and induces apoptosis. Nitric Oxide 2003;9:153-64
16. De Caterina R, Libby P, Peng HB, et al. Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest 1995;96:60-68
17. Hickey MJ, Sharkey KA, Sihota EG, et al. Inducible nitric oxide synthase-deficient mice have enhanced leukocyte-endothelium interactions in endotoxemia. Faseb J 1997;11:955-64
18. Hesse M, Cheever AW, Jankovic D, Wynn TA. NOS-2 mediates the protective anti-inflammatory and antifibrotic effects of the Th1-inducing adjuvant, IL-12, in a Th2 model of granulomatous disease. Am J Pathol 2000;157:945-55
19. Kim YM, Talanian RV, Billiar TR. Nitric oxide inhibits apoptosis by preventing increases in caspase-3-like activity via two distinct mechanisms. J Biol Chem 1997;272:31138-48
20. Lu D, Mahmood A, Zhang R, Copp M. Upregulation of neurogenesis and reduction in functional deficits following administration of DEtA/NONOate, a nitric oxide donor, after traumatic brain injury in rats. J Neurosurg 2003;99:351-61
21. Zhu DY, Liu SH, Sun HS, Lu YM. Expression of inducible nitric oxide synthase after focal cerebral ischemia stimulates neurogenesis in the adult rodent dentate gyrus. J Neurosci 2003;23:223-29
22. Bruce AJ, Boling W, Kindy MS, et al. Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors. Nat Med 1996;2:788-94
23. DeKosky ST, Styren SD, O'Malley ME, et al. Interleukin-1 receptor antagonist suppresses neurotrophin response in injured rat brain. Ann Neurol 1996;39:123-7
24. Gahm C, Holmin S, Mathiesen T. Nitric oxide synthase expression after human brain contusion. Neurosurgery 2002;50:1319-26
25. Sinz EH, Kochanek PM, Dixon CE, et al. Inducible nitric oxide synthase is an endogenous neuroprotectant after traumatic brain injury in rats and mice. J Clin Invest 1999;104:647-56
26. Lu J, Moochhala S, Shirhan M, et al. Neuroprotection by aminoguanidine after lateral fluid-percussive brain injury in rats: A combined magnetic resonance imaging, histopathologic and functional study. Neuropharmacology 2003;44:253-63
27. Gorlach C, Hortobagyi T, Benyo Z, Wahl M. Aminoguanidine reduces brain lesion volume after cold injury in the rat. Pflugers Arch 2000;440:309-14
28. Stoffel M, Rinecker M, Plesnila N, Eriskat J, Baethmann A. Attenuation of secondary lesion growth in the brain after trauma by selective inhibition of the inducible NO-synthase. Acta Neurochir Suppl 2000;76:357-58
29. Wada K, Chatzipanteli K, Kraydieh S, Busto R, Dietrich WD. Inducible nitric oxide synthase expression after traumatic brain injury and neuroprotection with aminoguanidine treatment in rats. Neurosurgery 1998;43:1427-36
30. Loihl AK, Whalen S, Campbell I, Mudgett JS, Murphy S. Transcriptional activation following cerebral ischemia in mice of a promoter-deleted nitric oxide synthase-2 gene. J Biol Chem 1999;274:8844-49
31. Grzybicki D, Moore SA, Schelper R, Glabinski AR, Ransohoff RM, Murphy S. Expression of monocyte chemoattractant protein (MCP-1) and nitric oxide synthase-2 following cerebral trauma. Acta Neuropathol (Berl) 1998;95:98-103
32. Baskin YK, Dietrich WD, Green EJ. Two effective behavioral tasks for evaluating sensorimotor dysfunction following traumatic brain injury in mice. J Neurosci Methods 2003;129:87-93
33. Mikawa S, Kinouchi H, Kamii H, et al. Attenuation of acute and chronic damage following traumatic brain injury in copper, zinc-superoxide dismutase transgenic mice. J Neurosurg 1996;85:885-91
34. Nakamura M, Saatman KE, Galvin JE, et al. Increased vulnerability of NFH-LacZ transgenic mouse to traumatic brain injury-induced behavioral deficits and cortical damage. J Cereb Blood Flow Metab 1999;19:762-70
35. Beaumont A, Marmarou A, Czigner A, et al. The impact-acceleration model of head injury: injury severity predicts motor and cognitive performance after trauma. Neurol Res 1999;21:742-54
36. Hamm RJ, Pike BR, O'Dell DM, Lyeth BG, Jenkins LW. The rotarod test: An evaluation of its effectiveness in assessing motor deficits following traumatic brain injury. J Neurotrauma 1994;11:187-96
37. Raghupathi R, Fernandez SC, Murai H, et al. BCL-2 overexpression attenuates cortical cell loss after traumatic brain injury in transgenic mice. J Cereb Blood Flow Metab 1998;18:1259-69
38. Morris R. Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods 1984;11:47-60
39. Harrison DC, Medhurst AD, Bond BC, Campbell CA, Davis RP, Philpott KL. The use of quantitative RT-PCR to measure mRNA expression in a rat model of focal ischemia-caspase-3 as a case study. Brain Res Mol Brain Res 2000;75:143-49
40. Knerlich F, Schilling L, Gorlach C, Wahl M, Ehrenreich H, Siren AL. Temporal profile of expression and cellular localization of inducible nitric oxide synthase, interleukin-1 beta and interleukin converting enzyme after cryogenic lesion of the rat parietal cortex. Brain Res Mol Brain Res 1999;68:73-87
41. Fee D, Crumbaugh A, Jacques T, et al. Activated/effector CD4+ T cells exacerbate acute damage in the central nervous system following traumatic injury. J Neuroimmunol 2003;136:54-66
42. Carbonell WS, Maris DO, McCall T, Grady MS. Adaptation of the fluid percussion injury model to the mouse. J Neurotrauma 1998;15:217-29
43. Scherbel U, Raghupathi R, Nakamura M, et al. Differential acute and chronic responses of tumor necrosis factor-deficient mice to experimental brain injury. Proc Natl Acad Sci U S A 1999;96:8721-26
44. Schneider G, Fries P, Wagner-Jochem D, et al. Pathophysiological changes after traumatic brain injury: Comparison of two experimental animal models by means of MRI. Magma 2002;14:233-41
45. Kamada K, Houkin K, Hida K, Iwasaki Y, Abe H. Serial changes in metabolism and histology in the cold-injury trauma rat brain model-proton magnetic resonance imaging and spectroscopy study. Neurol Med Chir (Tokyo) 1995;35:1-7
46. Taupin V, Toulmond S, Serrano A, Benavides J, Zavala F. Increase in IL-6, IL-1 and TNF levels in rat brain following traumatic lesion. Influence of pre- and post-traumatic treatment with Ro5 4864, a peripheral-type (p site) benzodiazepine ligand. J Neuroimmunol 1993;42:177-85
47. McIntosh TK, Smith DH, Meaney DF, Kotapka MJ, Gennarelli TA, Graham DI. Neuropathological sequelae of traumatic brain injury: Relationship to neurochemical and biomechanical mechanisms. Lab Invest 1996;74:315-42
48. Fink KB, Andrews LJ, Butler WE, et al. Reduction of post-traumatic brain injury and free radical production by inhibition of the caspase-1 cascade. Neuroscience 1999;94:1213-18
49. Orihara Y, Ikematsu K, Tsuda R, Nakasono I. Induction of nitric oxide synthase by traumatic brain injury. Forensic Sci Int 2001;123:142-49
50. Pearse DD, Chatzipanteli K, Marcillo AE, Bunge MB, Dietrich WD. Comparison of iNOS inhibition by antisense and pharmacological inhibitors after spinal cord injury. J Neuropathol Exp Neurol 2003;62:1096-1107
51. Clark RS, Kochanek PM, Schwarz MA, et al. Inducible nitric oxide synthase expression in cerebrovascular smooth muscle and neutrophils after traumatic brain injury in immature rats. Pediatr Res 1996;39:784-90
52. Petrov T, Underwood BD, Braun B, Alousi SS, Rafols JA. Upregulation of iNOS expression and phosphorylation of eIF-2alpha are paralleled by suppression of protein synthesis in rat hypothalamus in a closed head trauma model. J Neurotrauma 2001;18:799-812
53. Satake K, Matsuyama Y, Kamiya M, et al. Nitric oxide via macrophage iNOS induces apoptosis following traumatic spinal cord injury. Mol Brain Res 2000;85:114-22
54. Nag S, Picard P, Stewart DJ. Expression of nitric oxide synthases and nitrotyrosine during blood-brain barrier breakdown and repair after cold injury. Lab Invest 2001;81:41-49
55. Petrov T, Page AB, Owen CR, Rafols JA. Expression of the inducible nitric oxide synthase in distinct cellular types after traumatic brain injury: An in situ hybridization and immunocytochemical study. Acta Neuropathol (Berl) 2000;100:196-204
56. Ischiropoulos H, Zhu L, Chen J, et al. Peroxynitrite-mediated tyrosine nitration catalyzed by superoxide dismutase. Arch Biochem Biophys 1992;298:431-37
57. Lizasoain I, Moro MA, Knowles RG, Darley-Usmar V, Moncada S. Nitric oxide and peroxynitrite exert distinct effects on mitochondrial respiration which are differentially blocked by glutathione or glucose. Biochem J 1996;314:877-80
58. Radi R, Beckman JS, Bush KM, Freeman BA. Peroxynitrite-induced membrane lipid peroxidation: The cytotoxic potential of superoxide and nitric oxide. Arch Biochem Biophys 1991;288:481-87
59. Salgo MG, Bermudez E, Squadrito GL, Pryor WA. Peroxynitrite causes DNA damage and oxidation of thiols in rat thymocytes. Arch Biochem Biophys 1995;322:500-505
60. Liu D, Ling X, Wen J, Liu J. The role of reactive nitrogen species in secondary spinal cord injury: Formation of nitric oxide, peroxynitrite, and nitrated protein. J Neurochem 2000;75:2144-54
61. Whalen MJ, Clark RS, Dixon CE, et al. Reduction of cognitive and motor deficits after traumatic brain injury in mice deficient in poly(ADP-ribose) polymerase. J Cereb Blood Flow Metab 1999;19:835-42
62. Scott GS, Jakeman LB, Stokes BT, Szabo C. Peroxynitrite production and activation of poly (adenosine diphosphate-ribose) synthetase in spinal cord injury. Ann Neurol 1999;45:120-24
63. Mesenge C, Charriaut-Marlangue C, Verrecchia C, Allix M, Boulu RR, Plotkine M. Reduction of tyrosine nitration after N(omega)-nitro-L-arginine- methylester treatment of mice with traumatic brain injury. Eur J Pharmacol 1998;353:53-57
64. Bolanos JP, Almeida A, Stewart V, et al. Nitric oxide-mediated mitochondrial damage in the brain: Mechanisms and implications for neurodegenerative diseases. J Neurochem 1997;68:2227-40
65. Longhi L, Saatman KE, Raghupathi R, et al. A review and rationale for the use of genetically engineered animals in the study of traumatic brain injury. J Cereb Blood Flow Metab 2001;21:1241-58
66. Zhao X, Ross ME, Iadecola C. L-Arginine increases ischemic injury in wild-type mice but not in iNOS-deficient mice. Brain Res 2003;966:308-11
67. Loihl AK, Asensio V, Campbell IL, Murphy S. Expression of nitric oxide synthase (NOS)-2 following permanent focal ischemia and the role of nitric oxide in infarct generation in male, female and NOS-2 gene-deficient mice. Brain Res 1999;830:155-64
68. Cuzzocrea S, Chatterjee PK, Mazzon E, et al. Role of induced nitric oxide in the initiation of the inflammatory response after postischemic injury. Shock 2002;18:169-76
69. Barker JE, Knight KR, Romeo R, Hurley JV, Morrison WA, Stewart AG. Targeted disruption of the nitric oxide synthase 2 gene protects against ischaemia/reperfusion injury to skeletal muscle. J Pathol 2001;194:109-15
70. Iadecola C, Zhang F, Casey R, Nagayama M, Ross ME. Delayed reduction of ischemic brain injury and neurological deficits in mice lacking the inducible nitric oxide synthase gene. J Neurosci 1997;17:9157-64
71. Deitch EA, Shorshtein A, Houghton J, Lu Q, Xu D. Inducible nitric oxide synthase knockout mice are resistant to diet-induced loss of gut barrier function and intestinal injury. J Gastrointest Surg 2002;6:599-605
72. Gardner CR, Laskin JD, Dambach DM, et al. Reduced hepatotoxicity of acetaminophen in mice lacking inducible nitric oxide synthase: Potential role of tumor necrosis factor-alpha and interleukin-10. Toxicol Appl Pharmacol 2002;184:27-36
73. Hines IN, Kawachi S, Harada H, et al. Role of nitric oxide in liver ischemia and reperfusion injury. Mol Cell Biochem 2002;234-235:229-37
74. Sirsjo A, Lofving A, Hansson GK, Wagsater D, Tokuno S, Valen G. Deficiency of nitric oxide synthase 2 results in increased neointima formation in a mouse model of vascular injury. J Cardiovasc Pharmacol 2003;41:897-902
75. Kenyon NJ, van der Vliet A, Schock BC, Okamoto T, McGrew GM, Last JA. Susceptibility to ozone-induced acute lung injury in iNOS-deficient mice. Am J Physiol Lung Cell Mol Physiol 2002;282:L540-45
76. Kobayashi H, Hataishi R, Mitsufuji H, et al. Antiinflammatory properties of inducible nitric oxide synthase in acute hyperoxic lung injury. Am J Respir Cell Mol Biol 2001;24:390-97
77. Trajkovic V. Modulation of inducible nitric oxide synthase activation by immunosuppressive drugs. Curr Drug Metab 2001;2:315-29
78. Kroppenstedt SN, Stroop R, Kern M, Thomale UW, Schneider GH, Unterberg AW. Lubeluzole following traumatic brain injury in the rat. J Neurotrauma 1999;16:629-37
79. Stover JF, Schoning B, Sakowitz OW, Woiciechowsky C, Unterberg AW. Effects of tacrolimus on hemispheric water content and cerebrospinal fluid levels of glutamate, hypoxanthine, interleukin-6, and tumor necrosis factor-alpha following controlled cortical impact injury in rats. J Neurosurg 2001;94:782-87
80. Cash D, Beech JS, Rayne RC, Bath PM, Meldrum BS, Williams SC. Neuroprotective effect of aminoguanidine on transient focal ischaemia in the rat brain. Brain Res 2001;905:91-103
81. Faden AI, O'Leary DM, Fan L, Bao W, Mullins PG, Movsesyan VA. Selective blockade of the mGluR1 receptor reduces traumatic neuronal injury in vitro and improves outcome after brain trauma. Exp Neurol 2001;167:435-44
82. Yakovlev AG, Di X, Movsesyan V, et al. Presence of DNA fragmentation and lack of neuroprotective effect in DFF45 knockout mice subjected to traumatic brain injury. Mol Med 2001;7:205-16
83. Albensi BC, Knoblach SM, Chew BG, O'Reilly MP, Faden AI, Pekar JJ. Diffusion and high resolution MRI of traumatic brain injury in rats: Time course and correlation with histology. Exp Neurol 2000;162:61-72
84. Assaf Y, Beit-Yannai E, Shohami E, Berman E, Cohen Y. Diffusion- and T2-weighted MRI of closed-head injury in rats: A time course study and correlation with histology. Magn Reson Imaging 1997;15:77-85
85. Boer R, Ulrich WR, Klein T, Mirau B, Haas S, Baur I. The inhibitory potency and selectivity of arginine substrate site nitric-oxide synthase inhibitors is solely determined by their affinity toward the different isoenzymes. Mol Pharmacol 2000;58:1026-34
86. Huang PL. Neuronal and endothelial nitric oxide synthase gene knockout mice. Braz J Med Biol Res 1999;32:1353-59
87. Chen S, Pickard JD, Harris NG. Time course of cellular pathology after controlled cortical impact injury. Exp Neurol 2003;182:87-102